BioNTech SE (BNTX)
| Market Cap | 34.43B |
| Revenue (ttm) | 25.61B |
| Net Income (ttm) | 14.14B |
| Shares Out | 243.02M |
| EPS (ttm) | 55.75 |
| PE Ratio | 2.54 |
| Forward PE | 3.10 |
| Dividend | $2.13 (1.50%) |
| Ex-Dividend Date | Jun 2, 2022 |
| Volume | 687,675 |
| Open | 139.64 |
| Previous Close | 139.82 |
| Day's Range | 137.01 - 143.25 |
| 52-Week Range | 117.08 - 464.00 |
| Beta | -0.29 |
| Analysts | Buy |
| Price Target | 257.83 (+82.0%) |
| Earnings Date | Aug 8, 2022 |
About BNTX
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, ... [Read more...]
Financial Performance
In 2021, BioNTech SE's revenue was 18.98 billion, an increase of 3,834.63% compared to the previous year's 482.30 million. Earnings were 10.29 billion, an increase of 67,613.82%.
Financial numbers in EUR Financial StatementsAnalyst Forecast
According to 23 analysts, the average rating for BNTX stock is "Buy." The 12-month stock price forecast is 257.83, which is an increase of 81.97% from the latest price.
News
FDA recommends updating COVID booster shots to fight Omicron
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's vote to update its COVID-19 boosters.
FDA Panel Recommends Modifying COVID Jabs to Target Omicron
The FDA's VRBPAC committee recommends updated COVID-19 vaccine boosters that target the Omicron variant to improve vaccine effectiveness.
FDA advisers recommend Covid fall boosters
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on FDA advisers recommendation for covid fall boosters.
Why BioNTech Stock Rose Today
Its latest COVID-19 vaccine appears to be effective against the most common viral variants.
Pfizer/BioNTech's Updated Omicron-Based COVID-19 Shots Show Improved Response Against Variant
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said the modified vaccine against the omicron coronavirus variant generated a higher immune response. The companies said that 30 µg and 60 µg doses ...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omi...
NEW YORK and MAINZ, GERMANY, JUNE 25, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-a...
BioNTech Receives Priority Medicines (PRIME) Designation from EMA for Enhanced Regulatory Support of CAR-T Candidate ...
MAINZ, Germany, June 23, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced that that the European Medicines Agency (EMA) has granted Priority Medicines (PRI...
BioNTech breaks ground on first mRNA manufacturing facility in Africa in Kigali, Rwanda
BioNTech SE BNTX, +0.33% said Thursday it has broken ground on the construction of the first mRNA manufacturing facility in Africa, a plant in Kigali, Rwanda that is expected to employ about 100 workers...
BioNTech Starts Construction of First mRNA Vaccine Manufacturing Facility in Africa
MAINZ, Germany and KIGALI, Rwanda, June 23, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech”) has reached the next milestone in the establishment of scalable mRNA vaccine production in Afri...
Got $5,000? These 2 Growth Stocks Are Absurdly Cheap Buys
You'll get a lot of bang for your buck with these stocks.
COVID-19 vaccines slowly begin to roll out for young kids
Yahoo Finance's Anjalee Khemlani discusses the rollout of COVID vaccines for kids 6 months to 5 years, plus a new test that could indicate when a person needs a booster shot.
FDA Authorizes PFE & MRNA's COVID Jabs for 6 Months & Older Kids
FDA authorizes Pfizer (PFE) and BioNTech's Comirnaty for use in children aged six months through four years. Moderna's (MRNA) Spikevax gains EUA for use in individuals aged 6 months through 17 years.
BioNTech to Host First Edition of Innovation Series on Diversified Pipeline, Latest Technology Innovations
MAINZ, Germany, June 20, 2022 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or the "Company”) will host the first edition of the Company's Innovation Series on Wednesday, June 29th, 2022. Th...
Covid-19 Vaccinations For Children Starting At Age 6 Months Approved By CDC
Despite continued skepticism from parents and some scientific advisers, the Centers for Disease Control and Prevention on Saturday recommended Covid-19 vaccines for children as young as 6 months. The ru...
CDC Advisers Recommend COVID Vaccines for Kids as Young as 6 Months Old
Very young children may be able to start receiving shots early next week.
CDC panel recommends COVID-19 vaccine for children as young as 6 months old
"We've taken a major step forward today," said Dr. Oliver Brooks, one of the members of the advisory panel.
CDC advisers recommend COVID-19 shots for children under 5
U.S. health advisers on Saturday recommended COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.
CDC Panel Recommends Covid Vaccines For Young Children
Shots are expected to start going in arms next week.
CDC advisors recommend Covid vaccines for children as young as 6 months
The CDC committee voted unanimously to recommend the shots for use in infants through preschoolers after two days of meetings that were open to the public.
FDA Authorizes Covid Vaccine for Kids 5 and Under
Covid-19 vaccines for children ages 5 and under from Pfizer Inc. and Moderna Inc. received authorization from US regulators, meaning almost all the American population can soon get pandemic protection. ...
Moderna, Pfizer stocks edge higher after FDA authorizes COVID vaccines for kids
Yahoo Finance Live's Brian Sozzi reports that the FDA has authorized Moderna and Pfizer COVID vaccines for children under the age of 5.
FDA Approves COVID Vaccines for Kids as Young as 6 Months Old
Pending the CDC's signoff, both Moderna and Pfizer shots could be available for the youngest children within days.